Renaissance Technologies - CHECKMATE PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 26 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Renaissance Technologies ownership history of CHECKMATE PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2021$42,000
-70.0%
10,667
-54.6%
0.00%–
Q2 2021$140,000–23,500–0.00%–
 Download
Other shareholders
CHECKMATE PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 0$00.00%
View complete list of CHECKMATE PHARMACEUTICALS IN shareholders